Gland Pharma Limited has informed the Exchange regarding a press release dated August 26, 2025, titled "Gland Pharma receives approval from the United States Food and Drug Administration (USFDA) for Vasopressin 5% Dextrose Injection USP (RTU vial)".
Gland Pharma Limited has informed the Exchange regarding a press release dated August 26, 2025, titled "Gland Pharma receives approval from the United States Food and Drug Administration (USFDA) for Vasopressin 5% Dextrose Injection USP (RTU vial)".